Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Mapping and understanding alveolar cells in smokers with COPD

Official title: Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease

Run by Centre Hospitalier Intercommunal Creteil · NCT05227547 · Data updated 2026-11-12

This study is trying to understand how certain lung cells behave in smokers with COPD compared to non-smokers to learn more about how smoking affects lung repair.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment186 (estimated)
SponsorCentre Hospitalier Intercommunal Creteil
Academic / other
Drugs / interventionschemotherapy
Locations4 sites (Créteil and 3 other locations)
StatusRecruiting
StartedOctober 5, 2022
Main results expectedOctober 5, 2030
Study endsOctober 5, 2030
Registry record updatedSeptember 2, 2025
Trial IDNCT05227547 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are undergoing lung resection surgery for cancer or suspected cancer and are smokers with or without COPD.

Probably not a fit

Patients with chronic autoimmune diseases, those undergoing neo-adjuvant chemotherapy, or individuals who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the regenerative abilities of mesenchymal cells in the alveolar type 2 cells of patients undergoing thoracic surgery for suspected cancer. It focuses on smokers with and without chronic obstructive pulmonary disease (COPD) and compares them to non-smokers. The research aims to uncover the mechanisms behind the depletion of alveolar progenitor cells and their role in the pathophysiology of COPD. By analyzing the interactions between different cell populations in the alveolar stem cell niche, the study seeks to provide insights into lung repair processes affected by smoking and COPD.

Why it matters

Potential benefit: If successful, this study could lead to new therapeutic strategies for enhancing lung repair in patients with COPD.

How similar studies have gone: While similar studies have explored cell interactions in lung diseases, this specific approach to mapping alveolar cells in smokers with COPD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18
2. Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer
3. Acceptance to participate in the protocol
4. Affiliated to a social security plan

Exclusion Criteria:

1. Chronic autoimmune disease
2. Patient under guardianship or curators
3. Neo-adjuvant chemotherapy
4. History of thoracic radiotherapy
5. Pregnant woman
6. Minor patient
7. Person not able to consent
8. Person deprived of liberty

Where it's running

  • Rousseau-Bussac
    Créteil, France
    Recruiting
  • Hopital Cochin
    Paris, France
    Active not recruiting
  • Hegp
    Paris, France
    Active not recruiting
  • Hopital Tenon
    Paris, France
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.